Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

SCHERING OBTAINS MARKETING RIGHTS

March 17, 1992

MATRIX BEGINS TRIALS OF PROSTATE IMPLANT

March 17, 1992

IMAGING AGENT DETECTS INFECTIONS

March 17, 1992

MYCOGEN BREAKS INTO CALIFORNIA MARKET

March 17, 1992

COMPANY DISCLOSURE ROCKS STOCK

March 16, 1992

OFFERINGS UNDETERRED BY FLAT MARKET

March 16, 1992

CELLCOR IPO RAISES $22 MILLION

March 16, 1992

LIPO NETS $38.6 MILLION IN STOCK SALE

March 16, 1992

FDA MOVES QUICKLY ON HEPATITIS C TESTS

March 16, 1992

CELLPRO SYSTEM IN NEW GENE THERAPY TRIAL

March 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...